From: Comparison of gemcitabine and anthracycline antibiotics in prevention of superficial bladder cancer recurrence
Gemcitabine
Epirubicin or Pirarubicin
P
Recurrence
Yes
7 (8.33%)
18 (45%)
0.000
No
77 (91.67%)
22 (55%)
Progression
2 (2.38%)
8 (20%)
0.001
82 (97.62%)
32 (80%)
Treatment failure
10 (25%)
0.012
30 (75%)